Understanding Dysphagia: Challenges and Trials in Patient Care

The diagnostic odyssey

Dysphagia, or difficulty swallowing, is a condition that can significantly impact a patient's quality of life. It can arise from various causes, including neurological disorders, structural abnormalities, or even certain cancers. The burden of Dysphagia extends beyond the physical act of swallowing; it can lead to malnutrition, dehydration, and respiratory complications, making timely diagnosis and intervention critical.

Despite its prevalence, many patients remain undiagnosed or misdiagnosed, contributing to a lengthy and often frustrating diagnostic odyssey. Eligible patients for clinical trials are particularly challenging to identify, as the symptoms of Dysphagia can be subtle and vary widely among individuals. Moreover, the stigma associated with swallowing difficulties may prevent patients from seeking help, further complicating the identification of those who could benefit from innovative therapies.

The trial landscape right now

Currently, there are 12 recruiting clinical trials focused on Dysphagia, spread across 13 sites in 8 countries. This diverse geographical representation includes the United States, Turkey, the Netherlands, Italy, Canada, and Egypt. The trial landscape features a mix of early-phase and more advanced studies, with leading sponsors like Indiana University, IRCCS San Camillo in Italy, and Karl Landsteiner University of Health Sciences in Austria.

For instance, trial NCT04503785, sponsored by Indiana University, is investigating the relationship between esophageal impedance and manometry measurements alongside Dysphagia symptom scoring. Meanwhile, NCT05190718 focuses on the implementation of pharyngeal electrostimulation therapy for acute neurogenic Dysphagia, sponsored by Karl Landsteiner University of Health Sciences. These studies represent just a fraction of the ongoing efforts to understand and treat Dysphagia, highlighting the urgent need for effective therapies and improved patient outcomes.

How we detect the match

A novel approach to identifying eligible patients for Dysphagia clinical trials leverages an integration of HL7, FHIR, and artificial intelligence. By utilizing specific FHIR resources such as Condition, Observation, MedicationRequest, and DiagnosticReport, healthcare systems can automatically surface potential candidates from existing clinical data without the need for manual chart review.

This integration enables the identification of computable phenotypes based on lab results, genetic signals, and ICD-10 codes that indicate Dysphagia. For example, a patient's electronic health record may contain observations related to swallowing difficulties, medications prescribed for related conditions, and diagnostic reports that indicate a history of neurological disorders. By analyzing these data points, the system can efficiently flag individuals who meet trial eligibility criteria, streamlining the recruitment process and potentially accelerating the pace of research.

Beyond the trial: better care

The same integration that enhances trial recruitment also has significant implications for improving patient care. By shortening the diagnostic odyssey, healthcare providers can offer timely interventions for those experiencing Dysphagia, regardless of their participation in clinical trials. Enhanced coordination and monitoring can be achieved through real-time data sharing among care teams, allowing for more personalized treatment plans and proactive management of patients' conditions.

For instance, if a patient is flagged as having Dysphagia based on their clinical data, care teams can initiate a comprehensive assessment and begin appropriate therapies without delay. This proactive approach not only improves patient outcomes but also enhances overall healthcare efficiency, ensuring that patients receive the care they need when they need it.

The takeaway

Dysphagia presents significant challenges for patients and healthcare providers alike. While the current trial landscape shows promise with a variety of ongoing studies, innovative patient matching solutions using HL7 and FHIR combined with AI can transform the way eligible patients are identified and treated. By streamlining the diagnostic process and improving care coordination, we can enhance the quality of life for those living with Dysphagia and pave the way for more effective therapies.